# References

This file lists the primary sources cited in the implementation of
differential equation models and numerical methods used throughout this project.

[1] L. E. Friberg, A. Henningsson, H. Maas, L. Nguyen, and M. O. Karlsson, “Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs,” JCO, vol. 20, no. 24, pp. 4713–4721, Dec. 2002, doi: 10.1200/JCO.2002.02.140.

[2] A. Henrich et al., “Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia,” J Pharmacol Exp Ther, vol. 362, no. 2, pp. 347–358, Aug. 2017, doi: 10.1124/jpet.117.240309.

[3] V. Mangas-Sanjuan, N. Buil-Bruna, M. J. Garrido, E. Soto, and I. F. Trocóniz, “Semimechanistic Cell-Cycle Type–Based Pharmacokinetic/Pharmacodynamic Model of Chemotherapy-Induced Neutropenic Effects of Diflomotecan under Different Dosing Schedules,” The Journal of Pharmacology and Experimental Therapeutics, vol. 354, no. 1, pp. 55–64, Jul. 2015, doi: 10.1124/jpet.115.223776.

[4] P. Moritz et al., “Ray: A Distributed Framework for Emerging AI Applications,” 2017, arXiv. doi: 10.48550/ARXIV.1712.05889.

[5] C. Rackauckas et al., “Universal Differential Equations for Scientific Machine Learning,” Nov. 02, 2021, arXiv: arXiv:2001.04385. doi: 10.48550/arXiv.2001.04385.

[6] M. Steinacker, NARX-Hematox. (2024). Accessed: May 09, 2025. [Online]. Available: https://github.com/mariesteinacker/NARX-Hematox

[7] M. Steinacker, Y. Kheifetz, and M. Scholz, “Predicting chemotherapy-induced thrombotoxicity by NARX neural networks and transfer learning,” J Cancer Res Clin Oncol, vol. 150, no. 10, p. 457, Oct. 2024, doi: 10.1007/s00432-024-05985-y.
